Overview of Prosthetic Heart Valve MarketThe Global Prosthetic Heart Valve Market is valued at USD 8.74 Billion in 2024 and is projected to attain a value of USD 28.96 Billion by 2035 at a CAGR of 11.

MiRus announced new early feasibility study results supporting the use of its Siegel transcatheter aortic valve replacement ...

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.

HonorHealth Research Institute clinical trial, using non-surgical techniques, showed 86% of patients with a type of usually ...

NEW YORK CITY -- Heart valve innovation has made polymer valves a reality, with one such device boasting good 1-year outcomes ...

In a world defined by macroeconomic uncertainty and shifting geopolitical realities, Pella continues to find opportunities.

"Mitral annular calcification stiffens the structure of the mitral valve and can lead to mitral regurgitation or stenosis that disrupt the heart's ability to pump blood effectively.

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne™ transcatheter mitral valve replacement (TMVR) system to treat people with ...